International reference: 1 US FDA recall for this ingredient
Lack of Assurance of Sterility (polysulfate)
US-market enforcement records (OpenFDA), shown for reference - not specific to this product in Kenya.
What it does
Mucopolysaccharides are a type of carbohydrate that can be used in various treatments, particularly for conditions affecting joint function and mobility.
Commonly used for: osteoarthritis, rheumatoid arthritis, joint pain, inflammatory conditions
Read more in plain English ↓Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.
Ask about this medicine
Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.
Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.
Source this medicineRegistration & product details
Source: Pharmacy and Poisons Board · fetched 2026-01-28 19:57:36 · updated 2026-08-03 03:06:55
About mucopolysaccharide
Mucopolysaccharides are a type of carbohydrate that can be used in various treatments, particularly for conditions affecting joint function and mobility.
What it treats
- osteoarthritis
- rheumatoid arthritis
- joint pain
- inflammatory conditions
How it works
Mucopolysaccharides help to maintain the health of connective tissue, such as cartilage, and may reduce inflammation and improve joint function.
Who it's for
This treatment is generally for adults suffering from joint-related issues or conditions that affect mobility.
AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.
About polysulfate
Polysulfate is a medication used to help manage joint pain and improve mobility.
What it treats
- osteoarthritis
- joint pain
How it works
Polysulfate helps to reduce inflammation and protect cartilage in the joints.
Who it's for
This medication is for adults suffering from joint-related pain, especially those with osteoarthritis.
AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.
Clinical monograph: mucopolysaccharide
Mucopolysaccharides are a group of complex carbohydrates that play essential roles in the structure and function of connective tissues. They are composed of long chains of sugar molecules known as glycosaminoglycans, which include hyaluronic acid, chondroitin sulfate, and heparin, among others. These substances are critical for maintaining the structural integrity of tissues, lubrication in joints, and facilitating cellular signaling. Mucopolysaccharides are involved in various physiological processes, including growth, development, and repair of tissues.
Indications
- Osteoarthritis
- Rheumatoid arthritis
- Joint disorders
- Connective tissue diseases
- Wound healing
- Dry eye syndrome
Dosage
Children: Refer to specific product information and clinical guidelines for paediatric dosing
Adults: Refer to specific product information and clinical guidelines for detailed dosing instructions, as doses can vary based on the formulation and condition being treated.
Mechanism of action
Mucopolysaccharides exert their effects primarily through their ability to bind water and create a gel-like matrix, which enhances tissue hydration and elasticity. They interact with various proteins and cell surface receptors, influencing cellular behaviors such as proliferation, migration, and differentiation. Specific mucopolysaccharides, like hyaluronic acid, can also modulate inflammatory responses and tissue repair processes, promoting healing and reducing inflammation.
Pharmacodynamics
The pharmacodynamic properties of mucopolysaccharides are linked to their structural characteristics and their interaction with other biological molecules. They help to stabilize cell membranes, provide cushioning in joints, and play a role in the regulation of cell signaling pathways. By maintaining tissue hydration and elasticity, mucopolysaccharides can help alleviate symptoms in conditions such as osteoarthritis and other connective tissue disorders.
Pharmacokinetics
Mucopolysaccharides are typically administered via injection or topical application, as they are large molecules that do not easily cross biological membranes when taken orally. Once administered, they distribute throughout the extracellular matrix, where they exert their effects on local tissues. The metabolism of mucopolysaccharides primarily involves enzymatic degradation into shorter oligosaccharides, which may be further metabolized or excreted via the kidneys. Their half-life can vary significantly depending on the specific type of mucopolysaccharide and the route of administration.
Pregnancy
Mucopolysaccharides should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Consultation with a healthcare provider is essential.
Breast-feeding
It is not known whether mucopolysaccharides are excreted in human milk. Caution should be exercised when administering to nursing mothers.
Storage
Store at room temperature, away from light and moisture. Keep out of reach of children.
AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.
Clinical monograph: poly
Polyethylene glycol (PEG) is a polymer used primarily as an osmotic laxative in the treatment of constipation. It works by retaining water in the stool, which softens the stool and increases the number of bowel movements. PEG is often preferred due to its safety profile and lack of significant systemic absorption.
Indications
- Chronic constipation
- Occasional constipation
- Bowel preparation for diagnostic procedures
Dosage
Children: Refer to the BNF for Children for age-appropriate dosing information.
Adults: Refer to specific guidelines or the BNF for detailed dosing information.
Mechanism of action
Polyethylene glycol acts as an osmotic agent in the gastrointestinal tract. It retains water in the lumen of the intestines through osmosis, leading to an increase in stool moisture and volume. This effect promotes peristalsis and facilitates bowel movements.
Pharmacodynamics
PEG is not absorbed from the gastrointestinal tract, thereby acting locally within the intestines. Its osmotic effect draws water into the bowel, increasing the bulk of the stool and stimulating bowel motility. The drug is generally well tolerated, with minimal side effects compared to other laxatives.
Pharmacokinetics
Polyethylene glycol is characterized by its poor absorption. It remains in the gastrointestinal tract and is excreted unchanged in the feces. The onset of action can vary, typically occurring in 1 to 3 days after ingestion, depending on the dosage and individual patient factors.
Pregnancy
Poly is not recommended during pregnancy unless the potential benefits outweigh the risks. Consult a healthcare provider for individualized assessment.
Breast-feeding
Poly may be excreted in breast milk. Caution is advised when administering to nursing mothers, and a healthcare provider should be consulted.
Storage
Store in a cool, dry place away from light. Keep out of reach of children.
AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.
Clinical monograph: polysulfate
Polysulfate is a synthetic, semi-synthetic polysaccharide that is primarily used as an anti-inflammatory and analgesic agent. It acts primarily on the musculoskeletal system, helping to reduce pain and inflammation associated with conditions such as osteoarthritis and other joint disorders. Polysulfate is a component of some topical formulations and is known for its chondroprotective properties, which can help in the maintenance and repair of cartilage.
Indications
- Osteoarthritis
- Joint pain
- Inflammatory joint disorders
- Chronic musculoskeletal pain
Dosage
Children: Refer to the appropriate prescribing guidelines for specific paediatric dosages.
Adults: Refer to the appropriate prescribing guidelines for specific adult dosages.
Mechanism of action
Polysulfate works by inhibiting the synthesis of pro-inflammatory mediators and promoting the production of anti-inflammatory factors. It modulates the activity of various cytokines and enzymes involved in the inflammatory response, thereby reducing the inflammatory process in joints and tissues. Additionally, it may enhance the synthesis of glycosaminoglycans and proteoglycans, contributing to cartilage health.
Pharmacodynamics
Polysulfate exhibits anti-inflammatory and analgesic effects that are beneficial in the treatment of musculoskeletal pain. Its action on the inflammatory pathways in the body leads to a reduction in swelling and discomfort associated with joint diseases. The drug has been noted for its ability to restore synovial fluid composition and improve joint function over time.
Pharmacokinetics
Polysulfate is administered either topically or intramuscularly, with its pharmacokinetics varying based on the route of administration. Following administration, it is absorbed into the systemic circulation, where it may exert its therapeutic effects. The drug is metabolized in the liver, with its metabolites excreted primarily via the kidneys. The half-life and clearance rates can vary based on individual patient factors, including age and comorbidities.
Adverse effects
- Nausea
- Vomiting
- Diarrhea
- Abdominal pain
- Headache
- Dizziness
Precautions
- Use with caution in patients with renal impairment
- Monitor for gastrointestinal bleeding in patients with a history of ulcers
Pregnancy
Polysulfate should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Consult a healthcare provider.
Breast-feeding
Consult a healthcare provider before using polysulfate while breastfeeding, as it is unclear if it passes into breast milk.
Storage
Store at room temperature, away from moisture and heat. Keep out of reach of children.
Formulations
- Oral tablets
- Injectable solution
AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.